-+ 0.00%
-+ 0.00%
-+ 0.00%

ANNEXON INC - ENROLLMENT OF PHASE 3 ARCHER II TRIAL EXPECTED TO BE COMPLETED IN Q3 2025, WITH TOPLINE DATA EXPECTED IN SECOND HALF OF 2026

Reuters·06/18/2025 20:05:43

Please log in to view news